izpis_h1_title_alt

Men, testosterone and Covid‐19
ID Groti Antonić, Kristina (Avtor), ID Antonič, Blaž (Avtor), ID Caliber, Monica (Avtor), ID Dhindsa, Sandeep (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (621,64 KB)
MD5: A90C92F58D0B3322293E4BB84D0FC396
URLURL - Izvorni URL, za dostop obiščite https://onlinelibrary.wiley.com/doi/10.1111/cen.14952 Povezava se odpre v novem oknu

Izvleček
Men have more severe Coronavirus disease 2019 (Covid‐19) outcomes and higher mortality rates than women, and it was suggested that testosterone levels might promote severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and Covid‐19 severity. However, clinical studies have not supported this theory. Studies have consistently shown that serum testosterone concentrations during acute Covid‐19 in men are inversely proportional to the inflammatory cytokines and severity of illness. It is likely that lower testosterone concentrations in this setting are a result of acute Covid‐19 illness on the hypothalamic–pituitary–testicular axis. Clinical trials that attempted to lower testosterone concentrations further or block androgen signaling acutely during Covid‐19 in men did not result in improved Covid‐19 outcomes. Additionally, pre‐existing male hypogonadism, diagnosed before Covid‐19 pandemic, was found to be a risk factor for hospitalization from Covid‐19. In this review, we also discuss the preclinical and mechanistic studies that have evaluated the role of androgens in SARS‐CoV‐2 infection and illness. Finally, long‐term consequences of Covid‐19 on male reproductive health are reviewed. SARS‐CoV‐2 virus is known to infiltrate testis and induce orchitis in men, but it is unclear if Covid‐19 leads to an increase in incidence of male hypogonadism.

Jezik:Angleški jezik
Ključne besede:Covid‐19, hypogonadism, SARS‐CoV‐2, testes, testosterone
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:Str. 56-65
Številčenje:Vol. 100, iss. 1
PID:20.500.12556/RUL-159131 Povezava se odpre v novem oknu
ISSN pri članku:0300-0664
DOI:10.1111/cen.14952 Povezava se odpre v novem oknu
COBISS.SI-ID:201676803 Povezava se odpre v novem oknu
Datum objave v RUL:01.07.2024
Število ogledov:263
Število prenosov:56
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Clinical endocrinology
Skrajšan naslov:Clin. endocrinol.
Založnik:Wiley
ISSN:0300-0664
COBISS.SI-ID:25230336 Povezava se odpre v novem oknu

Licence

Licenca:CC BY-NC 4.0, Creative Commons Priznanje avtorstva-Nekomercialno 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc/4.0/deed.sl
Opis:Licenca Creative Commons, ki prepoveduje komercialno uporabo, vendar uporabniki ne rabijo upravljati materialnih avtorskih pravic na izpeljanih delih z enako licenco.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:COVID-19, hipogonadizem, SARS-CoV-2, moda, testosteron

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj